COVID-19 Treatment Drug Shows Promise in Clinical Trial

Published by Matt Fishman on

A COVID-19 treatment drug, called remdesivir, has shown promise as an effective treatment for the virus, according to the National Institutes of Health (NIH).

Clinical trials began on February 21, involving 1,063 COVID-19 patients. Patients receiving remdesivir “recovered faster than similar patients who received placebo”.

“Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo”. Recovery was defined as “being well enough for hospital discharge or returning to normal activity level.”

NIH’s review of remdesivir is the United State’s first clinical trial to evaluate a treatment for COVID-19.